ARMP News and Press, Armata Pharmaceuticals Inc. From 11/14/23

2023-11-14 17:11:39 ET More on Armata Pharmaceuticals Seeking Alpha’s Quant Rating on Armata Pharmaceuticals Historical earnings data for Armata Pharmaceuticals Financial information for Armata Pharmaceuticals For further details see: Armata Pharma...

Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update PR Newswire LOS ANGELES , Nov. 14, 2023 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pa...

Armata Pharmaceuticals Announces Presentation of Topline Data from SWARM-P.a. Clinical Study at the North American Cystic Fibrosis Conference PR Newswire LOS ANGELES , Oct. 30, 2023 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or t...

Armata Pharmaceuticals Announces Presentation at Phage Futures: Global Digital Summit 2023 PR Newswire LOS ANGELES , Oct. 19, 2023 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical stage biotechnology company focused on pa...

2023-10-09 13:48:03 ET Summary Innoviva, Inc. is a biopharma company focused on the development and commercialization of pharmaceutical products. However, the company's main asset is royalty revenues that come from products it receives from Glaxo Group Limited. There has been ...

Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a 'diSArm' Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus PR Newswire Initiation of the Phase 2a portion follows DRC review of positive safety and tolerabilit...

Armata Pharmaceuticals to Participate in the Cantor Global Healthcare Conference PR Newswire MARINA DEL REY, Calif. , Sept. 21, 2023 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a biotechnology company focused on pathogen-specific bacter...

2023-08-22 12:47:19 ET Gainers: VinFast Auto ( VFS ) +123% . AMTD Digital ( HKD ) +67% . Fulcrum Therapeutics ( FULC ) +51% . Hitek Global ( HKIT ) +30% . Fabrinet ( FN ) +28% . BioNexus Gene Lab Corp. ( BGLC ) +22% ....

2023-08-14 09:41:38 ET Armata Pharmaceuticals press release ( NYSE: ARMP ): Q2 GAAP EPS of -$0.17. Revenue of $0.98M (-47.9% Y/Y). For further details see: Armata Pharmaceuticals GAAP EPS of -$0.17, revenue of $0.98M

Armata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Update PR Newswire LOS ANGELES , Aug. 14, 2023 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on p...